Erectile dysfunction

Clinical Diabetes

Volumn 23, Issue 3, 2005, Pages 105-113

  Thethi, Tina K ^a   Asafu Adjaye, Nana O ^a   Fonseca, Vivian A ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIANDROGEN; ANTIARRHYTHMIC AGENT; C REACTIVE PROTEIN; CYCLIC GMP DERIVATIVE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PAPAVERINE; PHENTOLAMINE; PHOSPHODIESTERASE V INHIBITOR; PROSTAGLANDIN E1; SILDENAFIL; TADALAFIL; TESTOSTERONE; VARDENAFIL;

AUTONOMIC NEUROPATHY; CLINICAL FEATURE; COMORBIDITY; CORONARY ARTERY ATHEROSCLEROSIS; DIAGNOSTIC APPROACH ROUTE; DISEASE ASSOCIATION; DYSLIPIDEMIA; ENDOTHELIUM LESION; ERECTILE DYSFUNCTION; EXERCISE; HEALTH SURVEY; HEART REHABILITATION; HIGH RISK PATIENT; HUMAN; INJECTION PAIN; LABORATORY TEST; MEDICAL ASSESSMENT; MEDICAL EXAMINATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PATIENT INFORMATION; PATIENT SELECTION; PENIS PROSTHESIS; PREVALENCE; PROSTHESIS INFECTION; QT INTERVAL; QT PROLONGATION; REVIEW; RISK FACTOR; RISK MANAGEMENT; SEXUAL BEHAVIOR; TESTOSTERONE BLOOD LEVEL; VEIN DILATATION;

EID: 23744498952     PISSN: 08918929     EISSN: None     Source Type: Journal    
DOI: 10.2337/diaclin.23.3.105     Document Type: Review

References (59)

1. NIH Consensus Conference: Impotence: NIH Consensus Development Panel on Impotence. JAMA 270:83-90, 1993
2. Goldstein I, Lue TF, Padiabetesa-Nathan H, Rosen RC, Steers WD, Wicker PA: Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med 338:1397-1404, 1998
3. Shabsigh R, Klein LT, Seidiabetesan S, Kaplan SA, Lehrhoff BJ, Ritter JS: Increased incidence of depressive symptoms in men with erectile dysfunction. Urology 52:848-852, 1998
4. Romeo JH, Seftel AD, Madhun ZT, Aron DC: Sexual function in men with diabetes type 2: association with glycemic control. J Urol 163:788-791, 2000
5. Feldiabetesan HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB: Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 151:54-61, 1994
6. Kaiser FE: Erectile dysfunction in the aging man. Med Clin North Am 83:1267-1278, 1999
7. Richardson D, Vinik A: Etiology and treatment of erectile failure in diabetes mellitus. Curr Diab Rep 2:501-509, 2002
8. Fink HA, Mac DR, Rutks IR, Nelson DB, Wilt TJ: Sildenafil for male erectile dysfunction: a systematic review and meta-analysis. Arch Intern Med 162:1349-1360, 2002
9. Guay AT, Bansal S, Heatley GJ: Effect of raising endogenous testosterone levels in impotent men with secondary hypogonadism: double blind placebo-controlled trial with clomiphene citrate. J Clin Endocrinol Metab 80:3546-3552, 1995
10. Calles-Escandon J, Cipolla M: Diabetes and endothelial dysfunction: a clinical perspective. Endocr Rev 22:36-52, 2001
11. Fonseca V, Seftel A, Denne J, Fredlund P: Impact of diabetes mellitus on the severity of erectile dysfunction and response to treatment: analysis of data from tadalafil clinical trials. Diabetologia 47:1914-1923, 2004
12. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A: The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 49:822-830, 1997
13. Veves A, Akbari CM, Primavera J, Donaghue VM, Zacharoulis D, Chrzan JS, DeGirolami U, LoGerfo FW, Freeman R: Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration. Diabetes 47:457-463, 1998
14. Gazzaruso C, Giordanetti S, De Amici E, Bertone G, Falcone C, Geroldi D, Fratino P, Solerte SB, Garzaniti A: Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients. Circulation 110:22-26, 2004
15. Billups KL, Kaiser DR, Kelly AS, Wetterling RA, Tsai MY, Hanson N, Bank AJ: Relation of C-reactive protein and other cardiovascular risk factors to penile vascular disease in men with erectile dysfunction. Int J Impot Res 15:231-236, 2003
16. Levine LA, Kloner RA: Importance of asking questions about erectile dysfunction. Am J Cardiol 86:1210-1213, 2000
17. Bacon CG, Mittleman MA, Kawachi I, Giovannucci E, Glasser DB, Rimm EB: Sexual function in men older than 50 years of age: results from the health professionals follow-up study. Ann Intern Med 139:161-168, 2003
18. Derby CA, Mohr BA, Goldstein I, Feldman HA, Johannes CB, McKinlay JB: Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk? Urology 56:302-306, 2000
19. Kostis J, Jackson G, Rosen R, et al.: Sexual dysfunction and cardiac risk: the 2nd Princeton Consensus Conference. Am J Cardiol. In press
20. Nicolosi A, Glasser DB, Moreira ED, Villa M: Prevalence of erectile dysfunction and associated factors among men without concomitant diseaes: a population study. Int J Impot Res 15:253-257, 2003
21. Esposito K, Giugliano F, Di Palo C, Giugliano G, Marfella R, D'Andrea F, D'Armiento M, Giugliano D: Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA 291:2978-2984, 2004
22. Colberg SR, Stansberry KB, McNitt PM, Vinik AI: Chronic exercise is associated with enhanced cutaneous blood flow in type 2 diabetes. J Diabetes Compl 16:139-145, 2002
23. De Angelis L, Marfella MA, Siniscalchi M, Marino L, Nappo F, Giugliano F, De Lucia D, Giugliano D: Erectile and endothelial dysfunction in type II diabetes: a possible link. Diabetologia 44:1155-1160, 2001
24. Jiaan DB, Seftel AD, Fogarty J, Hampel N, Cruz W, Pomerantz J, Zuik M, Monnier VM: Age-related increase in an advanced glycation end product in penile tissue. World J Urol 13:369-375, 1995
25. Plante GE: Vascular response to stress in health and disease. Metabolism 51 (Suppl. 1):25-30, 2002
26. Seftel AD, Vaziri ND, Ni Z, Razmjouei K, Fogarty J, Hampel N, Polak J, Wang RZ, Ferguson K, Block C, Haas C: Advanced glycation end products in human penis: elevation in diabetic tissue, site of deposition, and possible effect through iNOS or eNOS. Urology 50:1016-1026, 1997
27. Xie Y, Garban H, Ng C, Rajfer J, Gonzalez-Cadavid NF: Effect of long-term passive smoking on erectile function and penile nitric oxide synthase in the rat. J Urol 157:1121-1126, 1997
28. Carson CC, Mulcahy JJ, Govier FE: Efficacy, safety and patient satisfaction outcomes of the AMS 700CX inflatable penile prosthesis: results of a long-term multicenter study. J Urol 164:376-380, 2000
29. Brock GB, McMahon CG, Chen KK, Costigan T, Shen W, Watkins V, Anglin G, Whitaker S: Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. J Urol 168:1332-1336, 2002
30. Porst H, Rosen R, Padma-Nathan H, Goldstein I, Giuliano F, Ulbrich E, Bandel T: The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first athome clinical trial. Int J Impot Res 13:192-199, 2001
31. Ebrahim S, May M, Ben Shlomo Y, McCarron P, Frankel S, Yarnell J, Davey Smith G: Sexual intercourse and risk of ischaemic stroke and coronary heart disease: the Caerphilly study. J Epidemiol Community Health 56:99-102, 2002
32. Feldman HA, Johannes CB, Derby CA, Kleinman KP, Mohr BA, Araujo AB, McKinlay JB: Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study. Prev Med 30:328-338, 2000
33. Kloner RA, Mitchell M, Emmick JT: Cardiovascular effects of tadalafil. Am J Cardiol 92:37M-46M, 2003
34. Mittleman MA, Glasser DB, Orazem J: Clinical trials of sildenafil citrate (Viagra) demonstrate noincrease in risk of myocardial infarction and cardiovascular death compared to placebo. Int J Clin Pract 57:597-600, 2003
35. Padma-Nathan H: Sildenafil citrate (Viagra) and erectile dysfunction: a comprehensive four year update on efficacy, safety, and management options. Urology 60:1-90, 2002
36. Arruda-Olson AM, Mahoney DW, Nehra A, Leckel M, Pellikka PA: Cardiovascular effects of sildenafil during exercise in men with known or probable coronary artery disease: a randomized crossover trial. JAMA 287:719-725, 2002
37. Fox KM, Thadani U, Ma PT, Nash SD, Keating Z, Czorniak MA, Gillies H, Keltai M, for the Clinical American and European Studies of Angina and Revascularization investigators: Sildenafil citrate does not reduce exercise tolerance in men with erectile dysfunction and chronic stable angina. Eur Heart J 24:2206-2212, 2003
38. Herrmann HC, Chang G, Klugherz BD, Mahoney PD: Hemodynamic effects of sildenafil in men with severe coronary artery disease. N Engl J Med 342:1622-1626, 2000
39. Reffelmann T, Kloner RA: Effects of sildenafil on myocardial infarct size, microvascular function and acute ischemic left ventricular dilation. Cardiovasc Res 59:441-449, 2003
40. Thadani U, Smith W, Nash S, Bittar N, Glasser S, Narayan P, Stein RA, Larkin S, Mazzu A, Tota R, Pomerantz K, Sundaresan P: The effect of vardenafil, a potent and highly selective phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction, on the cardiovascular response to exercise in patients with coronary artery disease. J Am Coll Cardiol 40:2006-2012, 2002
41. Morganroth J, Ilson BE, Shaddinger BC, Dabiri GA, Patel BR, Boyle DA, Sethuraman VS, Montague TH: Evaluation of vardenafil and sildenafil on cardiac repolarization. Am J Cardiol 93:1378-1383, 2004
42. Padma-Nathan H, Hellstrom WJ, Kaiser FE, Labasky RF, Lue TF, Nolten WE, Norwood PC, Peterson CA, Shabsigh R, Tam PY: Treatment of men with erectile dysfunction with transurethral alprostadil. Medicated Urethral System for Erection (MUSE) Study Group. N Engl J Med 336:1-7, 1997
43. Benet AE, Sharaby JS, Melman A: Male erectile dysfunction assessment and treatment options. Compr Ther 20:669-673, 1994
44. Moyad MA, Hathaway S, Ni HS: Traditional Chinese medicine, acupuncture, and other alternative medicines for prostate cancer: an introduction and the need for more research. Sem Urol Oncol 17:103-110, 1991
45. Guay AT, Spark RF, Jacobson J, Murray FT, Geisser ME: Yohimbine treatment of organic erectile dysfunction in a dose-escalation trial. Int J Impot Res 14:25-31, 2002
46. Ernst E, Pittler MH: Yohimbine for erectile dysfunction: a systematic review and meta-analysis of randomized clinical trials. J Urol 159:433-436, 1998
47. Morales A: Yohimbine in erectile dysfunction: the facts. Int J Impot Res 12:570-574, 2001
48. Ruck B, Shih RD, Marcus SM: Hypertensive crisis from herbal treatment of impotence. Am J Emerg Med 17:317-318, 1999
49. Zimmerman GA, McIntyre TM, Prescott SM: Adhesion and signaling in vascular cell-cell interactions. J Clin Invest 98:1699-1702, 1996
50. Tan RS, Pu SJ: Impact of obesity on hypogonadism in the andropause. Int J Androl 25:195-201, 2002
51. Leifke E, Gorenoi V, Wichers C, Von Zur MA, Von Buren E, Brabant G: Age-related changes of serum sex hormones, insulin-like growth factor-1 and sex-hormone binding globulin levels in men: cross-sectional data from a healthy male cohort. Clin Endocrinol (Oxf) 53:689-695, 2000
52. Spark RF, White RA, Connolly PB: Impotence is not always psychogenic: newer insights into hypothalamic-pituitary-gonadal dysfunction. JAMA 243:750-755, 1980
53. Fukui M, Kitagawa Y, Nakamura N, Kadono M, Mogami S, Hirata C, Ichio N, Wada K, Hasegawa G, Yoshikawa T: Association between serum testosterone concentration and carotid atherosclerosis in men with type 2 diabetes. Diabetes Care 26:1869-1873, 2003
54. Rhoden EL, Morgentaler A: Risks of testosterone-replacement therapy and recommendations for monitoring. N Engl J Med 350:482-492, 2004
55. Reffelmann T, Kloner RA: Therapeutic potential of phosphodiesterase 5 inhibition for cardiovascular disease. Circulation 108:239-244, 2003
56. Jevtich MJ, Edson M, Jarman WD, Herrera HH: Vascular factor in erectile failure among diabetics. Urology 19:163-168, 1982
57. Burchardt T, Burchardt M, Karden J, Buttyan R, Shabsigh A, de la Taille A, Ng PY, Anastasiadis AG, Shabsigh R: Reduction of endothelial and smooth muscle density in the corpora cavernosa of the streptozotocin induced diabetic rat. J Urol 164:1807-1811, 2000
58. Bemelmans BL, Meuleman EJ, Doesburg WH, Notermans SL, Debruyne FM: Erectile dysfunction in diabetic men: the neurological factor revisited. J Urol 151:884-889, 1994
59. Vernet D, Cai L, Garban H, Babbitt ML, Murray FT, Rajfer J, Gonzalez-Cadavid NF: Reduction of penile nitric oxide synthase in diabetic BB/WORdp (type I) and BBZ/WORdp (type II) rats with erectile dysfunction. Endocrinology 136:5709-5717, 1995